However, like many other “targeted” therapeutic agents, the anti-cancer efficacy of DJ4 may be enhanced by its ability to simultaneously target numerous signaling pathways relevant to cancer cell growth/survival/metastasis. This evidence concerns the gene DNAJB6 and cancer.